Literature DB >> 9430013

Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.

M Sasaki1, H Watanabe, J R Jass, Y Ajioka, M Kobayashi, K Matsuda, K Hatakeyama.   

Abstract

There is controversy about the prognostic significance of occult lymph node metastases detected by immunohistochemistry with the anti-cytokeratin antibody CAM 5.2. The aim of this study was to characterize occult lymph node metastases in colorectal carcinomas that might be associated with a higher risk of recurrence. Three hundred fifty-eight lymph nodes from 10 recurrent and 9 nonrecurrent cases of colorectal carcinoma were examined. All these patients had been reported originally as having no lymph node metastases by routine hematoxylin and eosin staining. Three 10-micron sections or ten 3-micron sections (30-micron total thickness) from each lymph node were stained with CAM 5.2 and examined for the presence of occult lymph node metastases. Occult metastases were detected in 67 of 175 lymph nodes from the recurrent cases, and in 23 of 183 lymph nodes from the nonrecurrent cases. The frequency of positive nodes was significantly higher in the recurrent cases. The recurrent cases had metastases in nodes more distant from the main tumor than did the nonrecurrent cases. Detection of occult lymph node metastases with cytokeratin immunohistochemistry may make it possible to identify patients with a higher risk of recurrence after the removal of a primary colorectal tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430013     DOI: 10.1007/bf02936951

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  16 in total

1.  The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.

Authors:  N Y Haboubi; P Clark; S M Kaftan; P F Schofield
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

2.  Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas.

Authors:  A G Nicholson; C G Marks; M G Cook
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.

Authors:  M H Galea; E Athanassiou; J Bell; B Dilks; J F Robertson; C W Elston; R W Blamey; I O Ellis
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

4.  Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; B Field; R White; W Brough; R Schellenberger; L F Watson
Journal:  Dis Colon Rectum       Date:  1990-11       Impact factor: 4.585

5.  Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins.

Authors:  D D Sedmak; T A Meineke; D S Knechtges
Journal:  Arch Pathol Lab Med       Date:  1989-07       Impact factor: 5.534

6.  Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method.

Authors:  N Hayashi; H Arakawa; H Nagase; A Yanagisawa; Y Kato; H Ohta; S Takano; M Ogawa; Y Nakamura
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

7.  The clinical significance of invasion of veins by rectal cancer.

Authors:  I C Talbot; S Ritchie; M H Leighton; A O Hughes; H J Bussey; B C Morson
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

Review 8.  Surgical treatment of tumor metastases: general considerations and results.

Authors:  F W Schildberg; G Meyer; S Piltz; H G Koebe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Genetic diagnosis of lymph-node metastasis in colorectal cancer.

Authors:  N Hayashi; I Ito; A Yanagisawa; Y Kato; S Nakamori; S Imaoka; H Watanabe; M Ogawa; Y Nakamura
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

10.  Occult axillary node metastases in breast cancer: their detection and prognostic significance.

Authors:  M A McGuckin; M C Cummings; M D Walsh; B G Hohn; I C Bennett; R G Wright
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more
  16 in total

1.  Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.

Authors:  Zhi-Wei Zhou; Nick Rieger; Andrew Ruszkiewicz; Guo-Qiang Wang; De-Sen Wan
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Entire-volume serial histological examination for detection of micrometastases in lymph nodes of colorectal cancers.

Authors:  Masaki Hata; Junji Machi; Jonathan Mamou; Eugene T Yanagihara; Emi Saegusa-Beecroft; Gregory K Kobayashi; Clifford C M Wong; Conway Fung; Ernest J Feleppa; Kazuhiro Sakamoto
Journal:  Pathol Oncol Res       Date:  2011-04-15       Impact factor: 3.201

3.  Lymph node micrometastasis in gallbladder cancer.

Authors:  Swati H Shah; Nikhil Gupta; Gurudutt Gupta; Anurag Mehta; Shivendra Singh
Journal:  Indian J Gastroenterol       Date:  2017-08-07

Review 4.  Clinical impact of minimal cancer cell detection in various colorectal cancer specimens.

Authors:  Kazuhiko Yoshimatsu; Hajime Yokomizo; Yoshihiko Naritaka
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 5.  Detection and clinical implications of minimal residual disease in gastro-intestinal cancer.

Authors:  Fabian Wolfrum; Ilka Vogel; Fred Fändrich; Holger Kalthoff
Journal:  Langenbecks Arch Surg       Date:  2005-07-01       Impact factor: 3.445

6.  Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Rodrigo Oliva Perez; Angelita Habr-Gama; Sidney Tomyo Nishida Arazawa; Viviane Rawet; Sheila Aparecida Coelho Siqueira; Desidério Roberto Kiss; Joaquim José Gama-Rodrigues
Journal:  Int J Colorectal Dis       Date:  2005-03-10       Impact factor: 2.571

7.  [Optimization of staging in colon cancer using sentinel lymph node biopsy].

Authors:  A Bembenek; U Schneider; S Gretschel; C Ulmer; P M Schlag
Journal:  Chirurg       Date:  2005-01       Impact factor: 0.955

Review 8.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

9.  Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.

Authors:  Robert Rosenberg; Jan Friederichs; Ralf Gertler; Axel Hoos; James Mueller; Jorg Nahrig; Hjalmar Nekarda; Joerg-Ruediger Siewert
Journal:  Int J Colorectal Dis       Date:  2004-01-10       Impact factor: 2.571

10.  Clinical significance of lymph node micrometastasis in stage I and II colon cancer.

Authors:  Sun Jin Park; Kil Yeon Lee; Si Young Kim
Journal:  Cancer Res Treat       Date:  2008-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.